Cargando…
Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy
While the treatment regimen of certain types of breast cancer involves a combination of hormonal therapy and chemotherapy, the outcomes are limited due to the difference in the pharmacokinetics of both treatment agents that hinders their simultaneous and selective delivery to the cancer cells. Herei...
Autores principales: | Mokhtar, Sarah, Khattab, Sherine N., Elkhodairy, Kadria A., Teleb, Mohamed, Bekhit, Adnan A., Elzoghby, Ahmed O., Sallam, Marwa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980280/ https://www.ncbi.nlm.nih.gov/pubmed/35392419 http://dx.doi.org/10.3389/fchem.2022.847573 |
Ejemplares similares
-
Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment
por: Salah, Mai, et al.
Publicado: (2022) -
Engineered Sericin-Tagged
Layered Double Hydroxides
for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible
Cancer Nanotheranostics
por: Abdelgalil, Riham M., et al.
Publicado: (2023) -
Combined Cancer
Immunotheranostic Nanomedicines: Delivery
Technologies and Therapeutic Outcomes
por: Nasser, Tasneem A., et al.
Publicado: (2023) -
Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
por: Elzoghby, Ahmed O., et al.
Publicado: (2020) -
Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
por: Zayed, Dina G., et al.
Publicado: (2019)